Chimerix CMRX has an Earnings ESP of +33.81% and a Zacks Rank of #2. Chimerix, Inc. (CMRX): Free Stock Analysis Report Factors at Play The ongoing inflationary pressure, a strengthening U.S. dollar and supply chain issues are expected to have adversely impacted Illumina’s third-quarter performance.